Tag: bioequivalence
Hatch-Waxman Act: How Federal Law Shapes Generic Drug Approval in the U.S.
Caspian Mortensen Feb, 11 2026 12The Hatch-Waxman Act revolutionized U.S. drug approval by enabling generic drugs to enter the market faster and cheaper. It balances innovation and competition, saving billions annually while facing new challenges from complex medicines.
More Detail
Long-Term Health After Switching to Generics: What You Need to Know
Caspian Mortensen Feb, 4 2026 1390% of prescriptions are generics, but long-term effects vary. Learn how bioequivalence standards miss key health risks, real patient experiences, and practical steps to stay safe after switching to generic drugs.
More Detail